HIV Grand Rounds UPenn Archive

 

Jointly sponsored by the Perelman School of Medicine at the University of Pennsylvania

 Perelman School of Medicine Small JPEG                   VE logo 300px

                                       GrandRound_ArchivedPilotSeries.jpg 

Content Links:

Series Overview
Target Audience
Commercial Support Acknowledgement
Learning Objectives for the Series
Course Directors
Faculty
Obtaining CME Credit for Archived Sessions: Important Information

 Archived Session Topics and Speakers
Hardware/Software Notice
Accreditation Statement/Credit Designation Statement
Disclosures
Disclosure of Unlabeled Use
Disclaimer
Return to Main Page

Series Overview: 

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the extension of this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet weekly and archived for on-demand viewing twenty-four hours after each live broadcast.

Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour activity consists of a question and answer period. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/grandrounds for easy access.  

Back to Top

Target Audience: 

This educational activity is designed for HIV specialists, Infectious Disease specialists, Internal Medicine specialists, Family Practice physicians, Dermatologists, Osteo-specialists, Nephrologists, Hematology/oncologist, Psychiatrists, Public Health professionals, OB/GYN physicians and other clinicians interested and involved in the care of patients with HIV/AIDS.

Back to Top
Commercial Support Acknowledgement: 

These activities are supported by educational grants from Gilead Sciences Medical Affairs and Janssen Pharmaceuticals, Inc.  

Back to Top
Learning Objectives for the Series: 

Upon completion of the educational activity, participants should be able to:

  • Improve knowledge and ability to use ARV therapy successfully;
  • Improve the knowledge of how drug adverse events, drug pharmacokinetics and patient adherence can affect ARV success and through the application of this knowledge avoid morbidity and mortality;
  • Improve knowledge of opportunistic infections and co-morbidities that may affect HIV-positive patients and increase their risk for morbidity and mortality;
  • Improve understanding of the importance of individualizing the care of each HIV-positive patient.
Back to Top
Course Directors: 
JohnBartlett  

John G. Bartlett, MD

Chief, Division of Infectious Diseases
Stanhope Bayne Jones Professor of Medicine
Director, HIV Care Program
Johns Hopkins School of Medicine
Baltimore, Maryland

CalvinCohen

Calvin J. Cohen, MD, MS

Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts

Ian Frank

Ian Frank, MD

Professor of Medicine,
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

   
Back to Top

Faculty: 


Jay Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division,
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania

  K. Rajender Reddy, MD
  Professor of Medicine,
  Professor of Medicine in Surgery,
  Director of Hepatology,
  Medical Director of Liver Transplantation
  University of Pennsylvania School of Medicine
  Philadelphia, Pennsylvania

Vincent Lo Re, III, MD
Clinical Associate Professor of Medicine,
Division of Infectious Diseases
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania

  Robert Siliciano, MD, PhD
  Professor of Medicine,
  Molecular Biology and Genetics,
  Howard Hughes Medical Institute
  Johns Hopkins University School of Medicine
  Baltimore, Maryland

Priscilla Hsue, MD
Associate Professor of Medicine,
Division of Cardiology
University of California, San Francisco
School of Medicine
San Francisco, California
Back to Top

  Louis J. Picker, MD
  Associate Director,
  Vaccine and Gene Therapy Institute
  Head, Pathobiology and Immunology Division
  Oregon Health and Science University
  Portland, Oregon

Timothy Wilkin, MD, MPH
Associate Professor of Medicine,
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York




  David Wohl, MD
  Associate Professor of Medicine,
  Division of Infectious Diseases, School of Medicine,
  The University of North Carolina, Chapel Hill, North Carolina
  Co-Director of HIV Services for the North Carolina
  Department of Corrections
  Chapel Hill, North Carolina 

Steven G. Deeks, MD
Professor of Medicine,
University of California, San Francisco
San Francisco, California

  Pablo Tebas, MD
  Professor of Medicine
  University of Pennsylvania
  Philadelphia, Pennsylvania

Todd Barton, MD
Associate Professor of Medicine,
The Perelman School of Medicine at the University of Pennsylvania 
Philadelphia, Pennsylvania


Back to Top

  Ian McGowan, MD
  Professor of Medicine,
  Division of Gastroenterology, Hepatology and Nutrition
  University of Pittsburgh School of Medicine
  Pittsburgh, Pennsylvania



Chloe L. Thio, MD
Professor of Medicine,
Division of Infectious Diseases
John Hopkins University
Baltimore, Maryland

  Renslow Sherer, MD
  Professor of Medicine,
  Section of Infectious Diseases and Global Health,
  University of Chicago
  Chicago, Illinois

Charles Hicks, MD
Professor of Medicine
Department of Infectious Diseases
Duke University Medical Center
Durham, North Carolina

  Beatrice Hahn, MD
  Professor of Medicine and Microbiology
  University of Pennsylvania
  Philadelphia, Pennsylvania



Robert M. Grant, MD, MPH
Betty Jean and Hiro Ogawa Endowed Investigator
Gladstone Institute of Virology and Immunology
Associate Professor of Medicine
University of California, San Francisco
San Francisco, California
Back to Top

  George M. Shaw, MD, PhD
  Professor of Medicine
  Division of Hematology / Oncology
  University of Pennsylvania 
  Philadelphia, Pennsylvania



Robert Gross, MD, MSCE
Associate Professor of Medicine
Infectious Diseases Division
Associate Professor of Epidemiology
Department of Biostatistics and Epidemiology
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania

  Doreen Ramogola-Masire, MD
  Country Director and Lead Physician Women's Health
  Botswana UPenn Partnership
  Gaborone, Botswana





James D. Neaton, PhD
Professor of Biostatistics
University of Minnesota School of Public Health
Minneapolis, Minnesota



  Una O'Doherty, MD, PhD
  Associate Professor of Pathology
  and Laboratory Medicine
  The Hospital of the University of Pennsylvania
  Philadelphia, Pennsylvania

Michel C. Nussenzweig, PhD
Sherman Fairchild Professor
Rockefeller University
Investigator, HHMI laboratory of Molecular Immunology
New York, New York

Back to Top

  Valerianna Amorosa, MD
  Chief of Infectious Diseases, VAMC Assistant Professor
  of Clinical Medicine
  The Perelman SOM at the University of Pennsylvania
  Philadelphia, Pennsylvania

Michael R. Betts, PhD
Assistant Professor
Department of Microbiology
Perelman School of Medicine
University of Pennsylvania







  Chris Beyrer, MD, MPH
 
Professor
  Director, Johns Hopkins Fogarty AIDS International
  Training and Research Program
  Director, Johns Hopkins Center for Public health
  and Human Rights
  Senior Scientific Liaison, HIV Vaccine Trials Network
  Associate Director of Public Health, Johns Hopkins Center for
  Public Health
  Baltimore, Maryland

Daniel Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine, Harvard Medical School
Boston, Massachusetts

  Thomas Coyne, MD, PhD
  Department of Pathology
  Hospital of the University of Pennsylvania
  Philadelphia, Pennsylvania



Jeffrey Hafkin, MD
Fellow, Infectious Diseases
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania 


  Amy Pruitt, MD
  Associate Professor of Neurology
  Hospital at the University of Pennsylvania
  Philadelphia, Pennsylvania

Ronald L. Wolf, MD, PhD
Associate Professor of Radiology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania





Back to Top

Corey Casper, MD, MPH
Associate Member, Vaccine and Infectious Disease, Public Health Science and Clinical Research Divisions
Fred Hutchinson Cancer Research Center
Associate Professor of Medicine, Epidemiology and Global Health University of Washington
Medical Director of Infection Control, Seattle Cancer Care Alliance
Seattle, Washington

Marshall J. Glesby, MD, PhD
Associate Professor of Medicine and
Associate Professor of Public Health 
Weill Cornell Medical College
Associate attending Physician 
New York-Presbyterian Hospital
New York, New York

David M. Margolis, MD
Professor of Medicine, Microbiology and Immunology,
Epidemiology
Director, Program in Translational Clinical Research
IGHID
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Peter W. Hunt, MD
Assistant Professor in Residence
University of California, San Francisco
San Francisco, California



Domenico Mavilio, MD, PhD
Group Leader,
Clinical and Experimental Immunology
Instituto Clinico Humanitas
Rozzano, Milano Italy

Luis Montaner, DVM, MSc, DPhil
Wistar Institute Professor of Medicine
Director, HIV-1 Immunopathogenesis Laboratory
The Wistar Institute
Philadelphia, Pennsylvania


Back to Top

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts
 
Roy M. Gulick, MD
Chief of the Division of Infectious Diseases
Professor of Medicine
Weill Medical College
Cornell University
New York, New York
 
Lawrence Corey, MD
President and Director
Fred Hutchinson Cancer Research Center
Professor, Medicine and Laboratory Medicine
University of Washington
Seattle, Washington

Vincent Lo Re III, MD
Clinical Associate Professor of Medicine,
Division of Infectious Diseases
Penn Presbyterian Medical Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Jay R. Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division,
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
Mark Sulkowski, MD
Associate Professor of Medicine and 
Medical Director, Viral Hepatitis Center
John Hopkins University School of Medicine
Baltimore, Maryland
 
Myron S. Cohen, MD
J. Herbert Bate Professor
Medicine, Microbiology and Immunology and Epidemiology
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina


Helen C. Koenig, MD, MPH
Clinical Assistant Professor 
Hospital at the University of Pennsylvania
Physician, LAX Center
Philadelphia, Pennsylvania
Back to Top

Baligh R. Yehia, MD, MSHP
Department of Medicine
University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania
 

Daniel E. Everitt, MD
Senior Medical Officer
TB Alliance
New York, New York



Martin Markowitz, MD
Clinical Director and Staff Investigator
Aaron Diamond AIDS Research Center
Aaron Diamond Professor at the Rockefeller University
New York, New York
 

Ned C. Sacktor, MD
Professor of Neurology
Johns Hopkins University School of Medicine
Joint Appointment, Department of International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland

Jennifer Cohn, MD, MPH
Assistant Professor and Director of the Global Health Equities Residency
University of Pennsylvania
Policy Advisor for East Africa for Medecins Sans Frontieres Access Campaign
Philadelphia, Pennsylvania
 
 
Robin J. Shattock PhD
Chair in Mucosal Infection and Immunity, Division of Infectious Diseases
Department of Medicine
Imperial College London
London, England

John W. Ward, MD
Director, Division of Viral Hepatitis
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Centers for Disease Control and Prevention
Atlanta, Georgia
 
 
Kenneth Hugh Mayer MD
Medical Research Director, Fenway Health
Attending Physician, Beth Israel Deaconess Medical Center
Visiting Professor, Harvard School of Public Health
Boston, Massachusetts
Back to Top

Elmi Muller, MD
Transplant Surgeon
Groote Schuur Hospital
Cape Town, South Africa
 

Karam Mounzer MD
Medical Director, Jonathan Lax Treatment Center
Clinical Associate Professor of Medicine
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania

Andrew J. Muir, MD MHS
Associate Professor of Medicine
Division of Gastroenterology
Director, Gastroenterology / Hepatology Research
Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina
 

Thomas J. Hope PhD
Professor
Department of Cell and Molecular Biology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Mohamed Atta MD MPH
Associate Professor of Medicine Renal Division
Johns Hopkins School of Medicine
Baltimore, Maryland
 

David Holtzman MD
Infectious Disease
University of Pennsylvania
Philadelphia, Pennsylvania
Back to Top

Marion G. Peters MD
Professor of Medicine
John V. Carbone MD Endowed Chair of Medicine
Chief of Hepatology Research
University of California
San Francisco, California
 

Kenneth E. Sherman MD PhD
Gould Professor of Clinical Medicine
Director, Division of Digestive Diseases
University of Cincinnati
Cincinnati, Ohio

Benoit Dubé MD
Assistant Professor of Clinical Psychiatry
Associate Director for Medical Student Education in Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
 

David Haas MD
Professor of Medicine
Professor of Pharmacology
Professor of Pathology, Microbiology and Imunology
Vanderbilt University School of Medicine
Nashville, Tennessee


 

Richard E. Chaisson MD
Professor of Medicine
Director, Center for Tuberculosis research
Director, Center for AIDS Research
Johns Hopkins University School of Medicine
Professor of Epidemiology and International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland


 

Marcus Altfeld MD PhD
Professor of Medicine, Harvard Medical School
The Ragon Institute of MGH, MIT and Hartford
Boston, Massachusetts
Back to Top

Hashem B. El-Serag, MD, MPH
Dan L. Duncan Professor of Medicine
Chief, Gastroenterology and Hepatology Section
Baylor College of Medicine
Houston, Texas
 

Susan Cu-Uvin, MD
Professor, Obstetrics and Gynecology and Medicine
Professor, Health Services, Policy and Practice
Director, Global Health Initiative
Brown University
The Miriam Hospital
Providence, Rhode Island

Peter S. Gilbert PhD
Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Principal Investigator, Statistical Center for the HIV Vaccine Trials Network
Research Professor, Department of Biostatistics
University of Washington
Seattle, Washington
 
 
Calvin J. Cohen, MD, MS

Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts


 
Ian Frank, MD

Professor of Medicine,
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania


 

Nezam H. Afdhal, MD

Professor of Medicine
Harvard Medical School
Chief of Hepatology, Director of Liver Center
Beth Israel Deaconess Medical Center
Boston, Massachusetts

   

Back to Top

Obtaining CME Credit for Archived Sessions: Important Information

This section pertains only to those who would like CME credit. If you do not want CME credit, please proceed to the next section below.

  • The Perelman School of Medicine at the University of Pennsylvania provides credit for all archived sessions in this educational activity.
  • If CME credit is desired for any of these sessions, proceed to http://penncmeonline.com/user/register to create your personal CME account, or if you already have an account, click the "Yes, I want CME credit" button below. You will be redirected to their website.
  • After your personal CME account is established this one time, you will receive an email with your initial login information. Follow the link in the email to change your password and complete the one-time profile set up. Additional instructions may be found at http://penncmeonline.com/user_guides.
  • A complete listing of all archived sessions, as listed below in the next section, can be found on the UPenn CME website. Follow the "Yes, I want CME Credit" button below to view the selections and earn CME credit. 
  • After clicking this button a new window will open and you will be redirected to the University of Pennsylvania Office of CME website for this activity.
Back to Top

Archived Session Topics and Speakers:


Each program below will be available for CME credit for one year. After that the programs will remain available for on-demand viewing only. Cessation of CME availability for any program over one year old will be noted by the quote: "This program is no longer available for CME credit but will remain available for viewing on demand."
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
 
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
 
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.

 Back to Top

 
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.

 This program is no longer available for CME credit but will remain available for viewing on demand.

 Back to Top

 

This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.
This program is no longer available for CME credit but will remain available for viewing on demand.

January 12th, 2012
Speaker:  Reuben S. Harris  PhD
Topic: The Feasibility of Modulating Cellular DNA Mutating Enzymes as Next-generation HIV/AIDS Therapeutics

This program is no longer available for CME credit but will remain available for viewing on demand.

January 19th, 2012
Speaker: Daniel R. Kuritzkes
 MD
Topic: Clinical Significance of HIV-1 Drug-resistant Minority Variants 

This program is no longer available for CME credit but will remain available for viewing on demand.

January 26th, 2012
Speakers: Ian Frank MD; Thomas Coyne MD PhD; Jeffrey Hafkin MD; Amy Pruitt MD; Ronald L. Wolf MD PhD

Topic: Real Cases from the Hospital of the University of Pennsylvania

  This program is no longer available for CME credit but will remain available for viewing on demand.   

 Back to Top

 

February 2nd, 2012
Speaker: Corey Casper MD MPH

Topic: The Spectrum and Pathogenesis of HIV-associated Malignancies in Resource-limited Settings

This program is no longer available for CME credit but will remain available for viewing on demand.

February 9th, 2012
Speaker: Marshall J. Glesby MD PhD

Topic: Update on the Cardiovascular Complications of HIV Infection 

This program is no longer available for CME credit but will remain available for viewing on demand.

This program is no longer available for CME credit but will remain available for viewing on demand.


February 23rd, 2012
Speaker: Peter W. Hunt MD

Topic: Inflammation and HIV Infection: A Paradigm Shift in the Management of HIV Disease

This program is no longer available for CME credit but will remain available for viewing on demand.
 

March 1st, 2012
Speakers: Ian Frank MD, Todd Barton MD & Valerianna Amorosa MD

Topic: Real Cases from the Hospital of the University of Pennsylvania: "Preventable" Lung Disease in HIV Infected Patients

This program is no longer available for CME credit but will remain available for viewing on demand.


March 9th, 2012
Speaker: Myron S. Cohen MD
Topic:
Prevention of HIV-1 Infection

This program is no longer available for CME credit but will remain available for viewing on demand.


March 15th, 2012
Speaker: Domenico Mavilio, MD, PhD
Topic: Natural Cytotoxicity Receptors: New Insights on Their Role in the Context of g/d T-cell Responses

 

March 22nd, 2012
Speaker: Ian Frank MD

Topic: Highlights from the 19th Conference on Retroviruses and Opportunistic Infections


March 29nd, 2012
Speaker:  Luis Montaner DMV MSc DPhil 

TopicHIV Control Mediated by Interferon-alpha Immunotherapy

 Back to Top

 

April 5th, 2012
Speaker: Paul E. Sax MD

Topic: Contemporary Issues in the Management of Treatment-Experienced Patients


April 12th, 2012
Speaker: Roy M. Gulick  MD MPH 

TopicART Controversies 2012

 

April 19th, 2012
Speaker: Lawrence Corey MD

Topic: Control of HSV Infection: The Action Is in the Mucosa

 

April 26th, 2012
Speaker: Vincent Lo Re MD & Jay Kostman MD

Topic: Case Studies from the Hospital at the University of Pennsylvania


May 3rd, 2012
Speaker: Mark Sulkowski MD

TopicAn Update from the Annual Meeting of the European Association for the Study of the Liver 


May 9th, 2012
Speaker: Myron S. Cohen  MD

Topic: Prevention of HIV-1 Infection

 

May 16th, 2012
Speaker: Brandon F. Keele PhD

Topic: Understanding HIV Transmission, Early Replication and Viral Dissemination Using Non-human Primate Models

 

May 24th, 2012
Speaker: Helen C. Koenig MD, MPH; Ian Frank, MD
TopicCase Studies from the Hospital of the University of Pennsylvania

 

May 31st, 2012
Speaker: Baligh R. Yehia MD, MSHP

TopicImproving Patient Retention in HIV Care

 

June 7th, 2012
Speaker: Daniel Everitt, MD
Topic: Developing New Therapies to Treat Tuberculosis

 Back to Top

 

June 14th, 2012
Speaker: Marty Markowitz, MD
Topic: Antiretroviral Therapy: Are Three Drugs Enough?


June 21st, 2012
Speaker: Ned C. Sacktor MD
Topic: Neurocognitive Dysfunction in Aging People with HIV Infection; An Emerging Epidemic?


June 28th, 2012
Speaker:  Calvin Cohen MD MSC, Ian Frank MD
Topic:  Real Cases...Not Necessarily from the Hospital at the University of Pennsylvania


September 13th, 2012
Speaker: Robin J. Shattock PhD
Topic:  Optimising Vaginal Humoral Immunity to HIV-1


September 20th, 2012
Speaker:  Ian Frank, MD
Topic: An Update from the XIX International AIDS Conference and 52nd ICAAC

September 27th, 2012
Speaker:  John W. Ward, MD
Topic:  Epidemiologic Challenges to Control and Eventual Elimination of HCV Transmission and Disease 

This is a re-broadcast of the Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania from September 26th, 2012

 

 

 Back to Top

 

October 25th, 2012
Speaker: Andrew J. Muir MD MHS
Topic:   Current Status of HCV Treatment:  Challenges, Expectations and Strategies for the Future

This is a re-broadcast of the Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania from October 24th, 2012


November 1st, 2012
Speaker:  Thomas J. Hope PhD
Topic:  Defining the Mechanisims of Heteresexual HIV Transmission
 


November 8th, 2012
Speaker:  Mohamed Atta MD MPH
Topic:  Renal Disease in HIV Infection


November 15th, 2012
Speaker:  Helen Koenig MD MPH; Amy Pruitt MD: David Holtzman MD
Topic: Real Cases from the University of Pennsylvania:  CNS Disease in Patients with a Decent CD4+ Count

 
 

November 29th, 2012
Speaker: Marian G Peters MD & Kenneth E. Sherman MD PhD
Topic: Treatment of HCV / HIV Co-infection & HIV / HEV Co-Infection

This is a re-broadcast of the Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania aired on November 28th, 2012


December 6th, 2012
Speaker:  Benoit Dubé MD FRCPC
Topic:  Treating Mental Illness in HIV Infected Patients


December 13th, 2012
Speaker:  David Haas MD
Topic: Pharmacogenomics of HIV infection


December 20th, 2012
Speaker: K. Rajender Reddy MD
Topic: An Update from the 63rd AASLD
 

 Back to Top

 

January 10th, 2013
Speaker: Richard E. Chaisson MD
Topic:  Preventing HIV-Related Tuberculosis: Two Steps Forward...

 

January 17th, 2013
Speaker: Marcus Altfeld MD PhD
Topic: Innate Immune Responses in HIV Infection


January 17th, 2013
Speaker:  Hashem B. El-Serag, MD MPH
Topic:  HCV Disease Burden - Now and the Future

This is a re-broadcast of the Viral Hepatitis Grand Rounds program webcast on 1/23/13

January 31st, 2013
Speaker:  Susan Cu-Uvin MD
Topic:  30 Years of Advances in HIV/AIDS:  What has Changed for Women?


February 7th, 2013
Speaker: Peter S. Gilbert, PhD
Topic: Analysis of Immune Correlates of Protection in RV144 HIV Vaccine Efficacy Trial


February 14th, 2013
Speaker: Calvin J. Cohen, MD MSc & Ian Frank, MD
Topic: Real Cases - Which ARV Regimens do We Start With...As of Feb 2013


February 21st, 2013
Speaker: Ian Frank, MD
Topic: Real Cases from the Hospital at the University of Pennsylvania

 

February 21st, 2013
Speaker: Nezm H. Afdhal, MD
Topic: new Concepts in Screening and Diagnosis of HCV
 

This is a re-broadcast of the Viral Hepatitis Grand Rounds program webcast on 2/27/13

Each program above will be available for CME credit for one year. After that the programs will remain available for on-demand viewing only.  Cessation of CME availability for any program over one year old will be noted by the quote: "This program is no longer available for CME credit but will remain available for viewing on demand."
Back to Top
The 26 one-hour pilot program lectures that ran from September 29, 2010 - May 4, 2011 are available for viewing.  Follow the button below to view these activities.
GrandRound_ArchivedPilotSeries.jpg  
Back to Top

Hardware/Software Notice:

You will need Internet to participate in this activity.

Accreditation Statement: 

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, LLC. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.
Back to Top

Credit Designation Statement: 

The Perelman School of Medicine at the University of Pennsylvania designates each enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Back to Top

Disclosures:

It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, LLC for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Belinda Rose, and Mindy Pollock Troy), our educational partner ViralEd, LLC (Richard Gordon, Brian Boyle, MD, JD and Ed Hettman), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Back to Top


John Bartlett, MD



Susan Cu-Uvin, MD



Robert Siliciano, MD



Todd Barton, MD



Chloe L. Thio, MD



Beatrice H. Hahn MD 



Peter S. Gilbert, PhD


 

Geroge M. Shaw, MD PhD



Doreen Ramogola-Masire, MD



James D. Neaton, PhD


 

Michel C. Nussenzweig, MD PhD


Back to Top


Valeriana Amorosa, MD



Michael Betts PhD


 

Chris Beyrer MD MPH



Reuben S. Harris PhD


   

Ian McGowan, MD



Una O'Doherty MD PhD



Thomas Coyne MD PhD



 Jeffrey Hafkin MD



Amy Pruitt MD



 Ronald L. Wolf MD PhD



Corey Casper MD MPH



Myrone S. Cohen MD



Domenico Mavilio MD PhD


Back to Top


Brandon F. Keele PhD


   

Helen C. Koenig MD



Baligh R. Yehia MD MSHP



Ned C. Sacktor MD 



Jennifer Cohn, MD



Robin J. Shattock PhD



John W. Ward MD



Elmi Muller MD



Thomas J. Hope PhD



David Holtzman MD 



Benoit Dubé MD



Hashem B. El-Serag,  MD MPH 


 
Back to Top
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:

Name

 

Commercial Supporter

Relationship


 

Calvin Cohen, MD

 

Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; ViiV

Contracted Research

   

Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; Abbott

Consulting Fees

   

Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec

Speakers Bureaus

 
 
   
 

Ian Frank, MD

 

GlaxoSmithKline

Contracted Research

   

Gilead

Consulting Fees

 
   
 

Vincent Lo Re, III, MD

 

AstraZeneca, Bristol-Myers Squibb

Contracted Research


 

K. Rajender Reddy, MD

 

Merck, Genentech-Roche, Vertex, Gilead, Janssen, BMS

Advisory Board 

   

Merck, BMS, Gilead, Vertex, Janssen, Abbot

Clinical Research - Support to the Institution

 
   
 

Priscilla Hsue, MD

 

Bristol-Myers Squibb, Gilead

Speakers Bureau

 
   
 

Louis Picker, MD       

 

CMV Vector Technology

Contracted Research

 
   
 
 Back to Top      

Timothy Wilkin, MD

 
 

GlaxoSmithKline

Contracted Research

 
   
 

David Wohl, MD

 

Merck & Co.; GlaxoSmithKline   

Contracted Research

   

Tibotec; Gilead; Bristol-Myers Squibb; Abbott

Consulting Fees

 
   
 

Steven Deeks, MD 

 

Merck & Co.; Gilead Sciences

Contracted Research

   

Tobira; ViiV

Consulting Fees

 
   
 

Pablo Tebas, MD

 

GlaxoSmithKline 

Adjudication Committee

   

Cytheris

DSMB Committee

   

GlaxoSmithKline; BMS; Gilead; Pfizer; Vertex; Inovio

Contracted Research

 Back to Top      
 
   
 

Renslow Sherer, MD  

 

BMS

Grant Support for Research

   

Abbott

Grant Support for Research

   

Gilead

Advisory Board with Honoraria  

   

Abbott

Advisory Board with Honoraria


 
 
 

 
Charles Hicks MD   Argos Grand Support -PI
    BMS; Gilead; Merck; Tibotec / Janssen; GSK/ViiV

Grant Support / Honorarium - PI / Advisory Board

 
   
 

Robert M. Grant MD MPH 

 

Gilead - Donation of study drug for NIH funded research

Investigator

 
   
 

Robert Gross, MD, MSCE

 

BMS

Research Investigator

 
   
 
Daniel R. Kuritzkes, MD   Abbott, BSC, Boehringer-Ingelheim, Gilead, Merck, Roche & ViiV

Consultant

    Gilead & Merclk Principal Investigator
 Back to Top   Roche Speaker
 
   
 
Marshall J. Glesby, MD, PhD   Pfizer; SIGA Technologies Consultant
    Pfizer Clinical Trial Researcher
 
   
 
David M. Margolis, MD   Merck, BMS, Gilead, GSK    Research & Materials Funding
    Gilead          Common Stocki
    Merck, BMS, GSK, Chimerix, Boehringer, ViiV Consulting Honaria
    Argos, Tibotec  Clinical Trial Funding
 
   
 
Peter W. Hunt, MD   Merck Consultant
    Pfizer, Salix, Roche Investigator-Initiated Study
    Boehringer-Ingelheim, Gilead Speaker
 
   
 
Luis J. Montaner, DVM, MSc, DPhil   Pfizer Research Investigator
 Back to Top      
 
   
 
Paul E. Sax, MD   Abbott, Aileron, BMS, Gilead, GSK, Merck, Tibotec Consultant
    BMS, Gilead, Merck, GSK, Tibotec Hospital Grant
       
 
   
 
Roy M. Gulick, MD, MPH   BMS, Gilead, Janssen Ad-hoc Consultant (honorarium)
       
 
   
 
Lawrence Corey, MD   Immune Design Corp Stock holder; Scientific Advisory Board
       
 
   
 
Vincent Lo Re III, MD   AstraZeneca, Bristol-Myers Squibb

Contracted Research

 Back to Top      
 
   
 
Jay Kostman, MD   Vertex                                                                                                                    Consultant
    Merck Consultant
       

 
 

 
Mark Sulkowski, MD   Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim Research Gra nt to John Hopkins University (PI)
    Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim Scientific Advisory Panel
       

 
 

 
Daniel E. Everitt, MD   

TB Alliance

Salary & Bonus as full time employee
   

PRESENTERS NOTE: The TB Alliance is a non-profit organization funded by government & private foundation (Gates) grants. It receives no revenue from product sales but works in partnerships to develop new drug regimens for treating tuberculosis.

 
       

 
 

 
Martin Markowitz, MD   Merck: Glead; Janssen; GSK; ViiV Consultatn = Honorarium
    Gilead; Janssen; BMS Speaker - Honorarium
 Back to Top      

 
 
 

 
Kenneth Hugh Mayer MD   Gilead, Merck & BMS

Research Grant for PI

       

 
 
 

 
Andrew J. Muir MD MHS  

Abbott, Achillion, BMS, Gilead, GSK, GlobeImmune, Medtronic, Merck, Pfizer, Roche, Salix, Scynexis, Vertex Pharmaceuticals

Grant / Research Funding

   

Achillion, BMS, Merck, Profectus BioSciences Inc., Scynexis, Vertex Pharmaceuticals

Consulting or Other Services (including CME)

 
 
 

 
Karam Mounzer MD   Gilead Sciences Research
    Gilead Sciences Speaker
       

 
 
 

Mohamed Atta MD MPH   GSK, BMS Advisory
    GSK Speaker
    Gilead Subcontract Grant PI
 Back to Top      

 
 
 

 
David W. Haas MD   Gilead Sciences, Merck, Boehringer-Ingelheim PI on research grant to Vanderbilt University
       

 
 
 

 
Richard E. Chaisson MD   Merck

Stock (wife is shareholder)

    Vertex

Consulting fees


 
 
 

 

Marcus Altfeld MD PhD

 

Gilead

Speaker Honorarium
       

Calvin J. Cohen, MD MSc

Gilead; Bristol-Myers Squibb; Merck & Co.

Contracted Research

 

Gilead; Bristol-Myers Squibb; Merck & Co.; Tobira

Honararia

Ian Frank, MD

Gilead

Advisor; honorarium

 

GlaxoSmithKline

Grant for Contracted research

Ian Frank, MD

Gilead

Advisor; honorarium

 

GlaxoSmithKline

Grant for Contracted research

Nezam H. Afdhal, MD Merck, GSK, Vertex, Gilead, Abbott, BMS Research Support
  Merck, Gilead, Echosens, GSK, Vertex, Novartis, Boehringer Ingelheim, Ligan, Springbank, Medgenics, Kadmon Consultant / Advisory Board Member
  Springbank, Medgenics Stock Options
Back to Top

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ViralEd, LLC, the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and Janssen Therapeutics do not recommend the use of any agent outside of the labeled indications. 
Product Investigational and/or Off-label Use

Amy Pruitt, MD

 
   Methohexate, rituxan, tenodex
Treatment of primary CNS lymphoma
 
 
Peter W. Hunt MD  
Dr. Hunt indicated that:
His presentation will contain discussion of ongoing research studies of drugs targeting immune activation in treated HIV infection with the understanding that these developments cannot yet be recommended for clinical use as there is no evidence to support their use at this time.
 Back to Top  
 
 
Luis J. Montaner, DVM, MSc, DPhil     
Interferon-alpha 2a (Roche/Genentech) Ind for HIV mono-infected
 
 
Roy M. Gulick, MD, MPH Investigational Antiretroviral Drugs (multiple)
 
 
Jay Kostman, MD  
Telaprevir Co-infection
Boceprevir Co-infection


Mark Sulkowski, MD Multiple experimental HCV agents
   

 

 
Daniel E. Everitt, MD Clofazimine - Investigational use to treate TB
  Moxifloxacin - Investigational use to treate TB
   


Calvin Cohen, MD, MSC  
All approved HIV Antivirals All Current studies exploring off label uses
Experimental HIV Antivirals Use of these for HIV treatment
 Back to Top  

 

 
Kenneth Hugh Mayer MD  
Maraviroc, Dapivirine. Rilpivirine Chemoprophylaxis
   

 

 
Amy Pruitt MD  
Mefloquine & Codofovir Progressiive Multifocal Leukoencephalopathy
Corticosteroids Immune Reconstitution Inflammatory syndrome / Progressiive Multifocal Leukoencephalopathy

 

 
Helen Koenig MD MPH  
Mirtazapine; Mefloquine; Cytarabine; Cidofovir Progressiive Multifocal Leukoencephalopathy Treatment

 

 
K. Rajendar Reddy MD I will mention several investigational drugs in clinical trials but will NOT discuss or promote off label use.  The gist of the talk is to discuss recent advances in HCV therapy.

 

 
Richard E. Chaisson MD  
Rifapentine Prevention of tuberculosis (currently labeled only for treatment of TB disease but recommended by the CDC for prevention
   

 

 
Marcus Altfeld MD PhD  
IMO-3100 (TLR 7/9 Antagonist) Investigational drug developed by Idera Pharmaceuticals for psoriasis
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of ViralEd, LLC, the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and Janssen Therapeutics. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Back to Top

Disclaimer: 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. 
Back to Top

GrandRoundsUpenn_ReturntoMainPrgm_button                                                    

You may contact Richard Gordon by phone at 1-856-506-5790 or by email at rgordon@viraled.com for additional assistance.

For CME questions please contact the Perelman School of Medicine at the University of Pennsylvania Office of CME:  upennCME@mail.med.upenn.edu.

We look forward to bringing the highest quality CME directly to you. 
Perelman School of Medicine Small JPEG                                                                                  VE logo 300px
Back to Top
Information Recommend this page to a friend! Prepare to print

Share this page:

Get link code to this page                     


Back to Top